CytomX Therapeutics Inc.

Company Listings from SPi: CytomX Therapeutics Inc.

You are here: Home >> SPi Company Listings >> CytomX Therapeutics Inc.

 

CytomX Therapeutics Inc.

Website:
http://

Search for other references to "cytomx" on SPi News

Latest CytomX Therapeutics Inc. News

CytomX Announces Appointment of Lloyd A. Rowland Jr. as General Counsel SOUTH SAN FRANCISCO, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX) a clinical-stage oncology-focused biopharmaceutical company pioneering a no...... 12:30 GMT Thursday 14th June 2018

CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annual Meeting SOUTH SAN FRANCISCO, Calif., June 04, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX) a clinical-stage oncology-focused biopharmaceutical company pioneering a no...... 14:00 GMT Monday 4th June 2018

CytomX Announces Conference Call and Webcast to Review PROCLAIM-072 Clinical Data Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting SOUTH SAN FRANCISCO, Calif., June 01, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX) a clinical-stage oncology-focused biopharmaceutical company pioneering a no...... 12:30 GMT Friday 1st June 2018

CytomX to Present at the Jefferies 2018 Healthcare Conference SOUTH SAN FRANCISCO, Calif., May 31, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a no...... 12:30 GMT Thursday 31st May 2018

CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-2029, a CD71-Directed Probody Therapeutic SOUTH SAN FRANCISCO, Calif., May 22, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX) a clinical-stage oncology-focused biopharmaceutical company pioneering a nov...... 12:30 GMT Tuesday 22nd May 2018

CytomX Therapeutics Announces Presentations at 2018 ASCO Annual Meeting SOUTH SAN FRANCISCO, Calif., May 16, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX) a clinical-stage oncology-focused biopharmaceutical company pioneering a nov...... 22:05 GMT Wednesday 16th May 2018

CytomX Therapeutics Announces First Quarter 2018 Financial Results SOUTH SAN FRANCISCO, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a no...... 21:05 GMT Wednesday 9th May 2018

CytomX to Present at the Bank of America Merrill Lynch 2018 Health Care Conference SOUTH SAN FRANCISCO, Calif., May 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a no...... 21:00 GMT Monday 7th May 2018

CytomX Therapeutics to Announce First Quarter 2018 Financial Results SOUTH SAN FRANCISCO, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage biopharmaceutical company developing investigational Probo...... 21:01 GMT Tuesday 1st May 2018

CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update SOUTH SAN FRANCISCO, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage biopharmaceutical company developing investigational Pro...... 21:30 GMT Wednesday 7th March 2018

Buy CytomX Therapeutics Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers